Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$122M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$89.5M |
| 3 |
Microsoft
MSFT
|
+$71.3M |
| 4 |
Visa
V
|
+$67M |
| 5 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$61.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$277M |
| 2 |
Micron Technology
MU
|
+$59M |
| 3 |
TCN
Tricon Residential Inc.
TCN
|
+$55.8M |
| 4 |
Zoetis
ZTS
|
+$48.4M |
| 5 |
Amgen
AMGN
|
+$48.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.69% |
| 2 | Industrials | 5.51% |
| 3 | Financials | 5.39% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Healthcare | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Kulicke & Soffa
KLIC
$4.37B
| $626K | ﹤0.01% |
+12,734
| New | +$599K |
|
|
GTLS
1702
DELISTED
Chart Industries
GTLS
| $626K | ﹤0.01% |
4,334
-2,011
| -32% | -$304K |
|
1703
Ionis Pharmaceuticals
IONS
$10.3B
| $624K | ﹤0.01% |
+13,098
| New | +$537K |
|
1704
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.5B
| $624K | ﹤0.01% |
+2,719
| New | +$624K |
|
1705
Driven Brands
DRVN
$2.15B
| $624K | ﹤0.01% |
48,989
-319,322
| -87% | -$4.04M |
|
1706
Idexx Laboratories
IDXX
$44.1B
| $624K | ﹤0.01% |
+1,280
| New | +$643K |
|
1707
Telos
TLS
$327M
| $623K | ﹤0.01% |
155,051
-55,389
| -26% | -$210K |
|
1708
CALL
Teradyne
TER
$57B
| $623K | ﹤0.01% |
4,200
-1,300
| -24% | -$165K |
|
1709
Acco Brands
ACCO
$387M
| $619K | ﹤0.01% |
131,614
-115,873
| -47% | -$578K |
|
1710
Alkami Technology
ALKT
$2.17B
| $618K | ﹤0.01% |
+21,708
| New | +$560K |
|
1711
iShares Select Dividend ETF
DVY
$23.9B
| $618K | ﹤0.01% |
+5,109
| New | +$620K |
|
1712
CALL
Saia
SAIA
$9.32B
| $617K | ﹤0.01% |
1,300
-600
| -32% | -$279K |
|
1713
Consolidated Edison
ED
$39.8B
| $613K | ﹤0.01% |
+6,860
| New | +$636K |
|
|
AVNS
1714
DELISTED
Avanos Medical
AVNS
| $613K | ﹤0.01% |
30,762
-45,094
| -59% | -$878K |
|
|
SILK
1715
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $611K | ﹤0.01% |
22,589
-118,586
| -84% | -$2.47M |
|
1716
CALL
Casey's General Stores
CASY
$31.6B
| $610K | ﹤0.01% |
+1,600
| New | +$534K |
|
1717
PUT
Comfort Systems
FIX
$56.7B
| $608K | ﹤0.01% |
+2,000
| New | +$636K |
|
1718
iShares US Aerospace & Defense ETF
ITA
$14B
| $608K | ﹤0.01% |
+4,604
| New | +$610K |
|
1719
CALL
Darden Restaurants
DRI
$25.6B
| $605K | ﹤0.01% |
+4,000
| New | +$609K |
|
1720
Vir Biotechnology
VIR
$1.68B
| $604K | ﹤0.01% |
67,904
+3,089
| +5% | +$29.6K |
|
1721
Weatherford International
WFRD
$6.36B
| $603K | ﹤0.01% |
+4,927
| New | +$588K |
|
1722
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
| $603K | ﹤0.01% |
+7,178
| New | +$591K |
|
1723
CALL
Camtek
CAMT
$6.64B
| $601K | ﹤0.01% |
+4,800
| New | +$458K |
|
1724
Immatics
IMTX
$1.19B
| $597K | ﹤0.01% |
51,379
+25,946
| +102% | +$292K |
|
1725
First Financial Corp
THFF
$947M
| $595K | ﹤0.01% |
+16,144
| New | +$593K |
|
Similar funds
Paul Tudor Jones's Q2 2024 Portfolio in Review
As of Q2 2024, Paul Tudor Jones held 2,929 positions worth $19.5B, up 24% from $15.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Paul Tudor Jones deployed $4.18B of net new capital in Q2 2024, opening 786 new positions and adding to 755 existing holdings. Its largest new stake was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 8.9% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $59M trimmed.
- Paul Tudor Jones's largest Q2 2024 buy was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
- Paul Tudor Jones added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $122M increase.
- Paul Tudor Jones's biggest Q2 2024 reduction was Micron Technology, cutting an estimated $59M.
- Paul Tudor Jones fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $277M.
- Paul Tudor Jones's ten largest holdings make up 34% of its $19.5B portfolio in Q2 2024.
- Paul Tudor Jones opened 786 new positions and closed 671 in Q2 2024.
- Paul Tudor Jones's portfolio value rose 24% quarter-over-quarter to $19.5B.
Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.